EGFR and lung adenocarcinoma: A 69‐year‐old woman diagnosed with stage IVB (cT2aN2M1c) EGFR exon 21 mutation‐positive lung adenocarcinoma with multiple bone and thyroid metastases (Figure 1) and Eastern Cooperative Oncology Group (ECOG) performance status 2.